A recent case report about a man who received an mRNA-based COVID-19 vaccine suggests that taking the vaccine “may trigger immune-mediated hepatitis,” researchers wrote.
The natural immunity provided by COVID-19 infection in unvaccinated adults is on par with protection conferred from vaccines against reinfection with or hospitalization from the virus, a new study reveals.
Judicial Watch today announced it received 466 pages of records from the U.S. Department of Health and Human Services (HHS) regarding biodistribution studies and related data for the COVID-19 vaccines that show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals, eight to 48 hours after injection.
Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants.
"Antibodies produced by vaccinated and boosted people may not stop omicron SARS-CoV-2 strain from entering cells as well as it stops original virus," say Johns Hopkins researchers.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,237,647 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and April 15, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
Heart inflammation requiring hospital care was more common among people who received COVID-19 vaccines than those who did not, according to a new study of tens of millions of Europeans.
